Skip to main content

Clinical Data

Surgeons Image
Biogennix advanced bone graft products have a long history of clinical use. In the past 9 years, our products have been successfully used in over 50,000 surgeries.
Based on the innovative TrelCor technology platform, Biogennix bone grafting products provide surgeons with next-generation bone graft material that enhances the bone healing process.
These products are available in a variety of configurations that are compatible with commonly bone grafting techniques. All products are simple to use, can reduce OR time, and will provide unmatched intraoperative handling.

Common Surgical Uses

AGS on Spine_Hyrdated
Ankle Arthrodesis
Foot & Ankle
Long Bone Void_CloseUp
General Orthopedics

Spine Fusion Clinical Study

The clinical effectiveness of TrelCor advanced bone graft material granules was evaluated in a multi-center, 60-patient spinal fusion study. Patients were surgically treated with a 1-3 level lumbar interbody fusion. A combination of granules and autograft was used in the posterolateral space with standard interbody and posterior hardware placement. Radiographic fusion was assessed at each follow-up point using a 4 point scale: Grade 1 (no fusion), Grade 2 (incomplete fusion), Grade 3 (complete fusion), Grade 4 (solid fusion).

The results showed increasing fusion scores from 6 months to 1 year. At <6 months, the average fusion score was Grade 2 indicating a progressing fusion. At 7-10 months, scores increased to 3.2 with bridging fusion across the site. At 12 months, the fusion masses showed solid fusion with radiographically mature bone. The overall 12-month result showed fusion in 59 out of 60 patients (98% fusion rate). Overall both surgeons and patients were satisfied with the clinical outcomes.

Because the journey to great outcomes starts with great decisions.

Trust the leader in advanced bone regeneration technology. Your success drives everything we do.

Schedule a Call